Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (40)

2024

  1. Basic action protocol for the outpatient management of chronic heart failure of the Spanish Society of Internal Medicine

    Revista Clinica Espanola

  2. Clinical suspicion, diagnosis and management of cardiac amyloidosis: update and executive summary

    Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 288-299

  3. Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial

    JACC: Heart Failure, Vol. 12, Núm. 10, pp. 1719-1730

  4. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  5. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease

    Clinical Kidney Journal, Vol. 17, Núm. 6

  6. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  7. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

    Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 50-59

  8. Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial

    Revista Clinica Espanola, Vol. 224, Núm. 2, pp. 67-76

  9. The significance of metabolic alkalosis on acute decompensated heart failure: the ALCALOTIC study

    Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1251-1262

  10. The two different profiles in heart failure with preserved ejection fraction and type 2 diabetes mellitus: ischemic and diabetic

    Current Medical Research and Opinion, Vol. 40, Núm. 3, pp. 359-366

  11. Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry

    Cardiorenal medicine, Vol. 14, Núm. 1, pp. 543-555

2023

  1. Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post-hoc analysis of the CLOROTIC trial

    European Journal of Heart Failure, Vol. 25, Núm. 10, pp. 1784-1793

  2. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

    European heart journal, Vol. 44, Núm. 5, pp. 411-421

  3. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

    Revista Espanola de Cardiologia

  4. Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice

    Future cardiology, Vol. 19, Núm. 6, pp. 343-351

2022

  1. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction

    Medicina Clinica, Vol. 159, Núm. 4, pp. 164-170

  2. Causes of death in hospitalized patients in internal medicine departments with heart failure according to ejection fraction. RICA registry

    Medicina Clinica, Vol. 158, Núm. 1, pp. 13-19

  3. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

  4. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 359-369

2021

  1. Cognitive impairment in patients hospitalized for congestive heart failure: data from the RICA Registry

    Internal and Emergency Medicine, Vol. 16, Núm. 1, pp. 141-148